Ozempic vs Wegovy

What the trials showed

Wegovy’s doses were tested for weight loss. Ozempic’s were not. That is the whole reason the two brands report different numbers.

Both brands have a cardiovascular outcomes trial, in different populations. The size of the effect is similar.

Two Wegovy indications have no Ozempic counterpart. In ESSENCE, 2.4 mg produced combined resolution of steatohepatitis and fibrosis improvement in 32.7% of patients with MASH, versus 16.1% on placebo, which earned an accelerated approval for that indication. And in SELECT, weight loss on 2.4 mg was sustained for four years: 10.2% at 208 weeks versus 1.5% on placebo.

Ozempic’s own trials answer a diabetes question. In SUSTAIN FORTE, 2 mg beat 1 mg on HbA1c with about 0.9 kg of extra weight loss over 40 weeks. In FLOW, semaglutide cut major kidney events by 24% in people with type 2 diabetes and chronic kidney disease, and all-cause death by 20%.

The dose ladders

Both start at 0.25 mg. They part ways at step four.

Ozempic escalates only when glucose control calls for it. Wegovy escalates on a fixed calendar. A 1 mg dose is a maintenance option on one label and a transit stop on the other, which is why “I take 1 mg” tells you nothing about which brand it is.

What comes out of the box

Ozempic ships as a multi-dose pen. Three strengths cover the ladder: a 2 mg/3 mL pen delivering 0.25 or 0.5 mg doses, a 4 mg/3 mL pen delivering 1 mg, and an 8 mg/3 mL pen delivering 2 mg. Single-dose prefilled syringes at 0.25, 0.5, and 1 mg are also listed.

Wegovy ships as single-dose pens at every step, 0.25 through 2.4 mg, plus a 7.2 mg pen branded Wegovy HD, single-dose syringes, and a four-dose FlexTouch pen holding 9.6 mg. One device per injection versus one device per month is the practical difference people notice first.

The tablets

The Wegovy label now includes tablets at 1.5, 4, 9, and 25 mg, started at 1.5 mg daily for 30 days and stepped up monthly to 25 mg. In OASIS 4, the 25 mg tablet produced 13.6% mean weight loss over 64 weeks versus 2.2% on placebo, close to the injection’s STEP 1 result.

There is no Ozempic tablet on the Ozempic label. Ozempic-branded tablets at 1.5, 4, and 9 mg exist, but they sit on the oral semaglutide label shared with Rybelsus, and that label states the tablets and the injection are not interchangeable milligram for milligram.

Every tablet form has the same rule: on waking, empty stomach, no more than 4 ounces of water, and nothing else for 30 minutes. The rule exists because oral semaglutide absorption is fragile.

What is identical

The safety sections. Both labels open with the boxed warning on thyroid C-cell tumors, both are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2, and both carry the same warnings on pancreatitis, gallbladder disease, severe gastrointestinal reactions, and acute kidney injury from dehydration. Neither brand is the gentler one.

Which comparison you wanted

• Ozempic against Lilly’s diabetes brand: Ozempic vs Mounjaro.
• Wegovy against Lilly’s obesity brand: Wegovy vs Zepbound.
• The injection against the tablet: Ozempic vs Rybelsus.
• The approved pen against a pharmacy vial: Wegovy vs compounded semaglutide.
• Lilly’s equivalent brand split: Zepbound vs Mounjaro.

Whichever brand is on the pen, the log entry is the same: product, date, milligrams, site. How GLP-1 tracking works covers what to record.

7. Ozempic vs Wegovy FAQ

• Is Ozempic the same as Wegovy?

  The active ingredient is identical: semaglutide, injected once weekly. The labels differ. Ozempic is approved for type 2 diabetes and its cardiovascular and kidney complications with a 2 mg ceiling. Wegovy is approved for weight reduction, cardiovascular risk reduction with obesity, and MASH, with a 2.4 mg maintenance dose and a 7.2 mg option for weight reduction.

• Does Wegovy cause more weight loss than Ozempic?

  No trial has compared the two brands. Wegovy's doses have been tested for weight loss and Ozempic's have not. In STEP UP, 7.2 mg produced 18.7% mean weight loss versus 15.6% for 2.4 mg. In STEP 2, in people with type 2 diabetes, 2.4 mg produced 9.6% versus 3.4% for placebo.

• Which one lowers heart attack and stroke risk?

  Both, in the populations each was tested in. SELECT tested the Wegovy dose in people with cardiovascular disease and obesity but no diabetes: 6.5% had an event versus 8.0% on placebo. SUSTAIN-6 tested Ozempic doses in people with type 2 diabetes: 6.6% versus 8.9%.

• Is there an Ozempic pill and a Wegovy pill?

  There is a Wegovy tablet, in 1.5, 4, 9, and 25 mg strengths, on the Wegovy label. Ozempic tablets in 1.5, 4, and 9 mg exist but sit on the Rybelsus oral semaglutide label, not the Ozempic injection label.

• Can I use Ozempic for weight loss?

  Weight reduction is not on the Ozempic label. Whether to prescribe any semaglutide product, and which one, is a decision for a prescriber and depends on diagnosis, coverage, and the label.

8. Sources